Muthusamy Shanmugam - 17 Mar 2022 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam
Issuer symbol
ANIP
Transactions as of
17 Mar 2022
Transactions value $
$276,503
Form type
4
Filing time
21 Mar 2022, 21:58:12 UTC
Previous filing
23 Nov 2021
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Purchase $138K +5K +37.15% $27.65 18.5K 17 Mar 2022 Direct F1
transaction ANIP Common Stock Purchase $138K +5K $27.65 5K 17 Mar 2022 Held by SS Pharma LLC F1, F2
holding ANIP Common Stock 1.33M 17 Mar 2022 Held by Esjay LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired in multiple trades at prices ranging from $27.36 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
F3 The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.